Cargando…

Real-World Data of Adherence and Drug Survival of Biologics in Treatment-Naïve and Treatment-experienced Adult Patients with Rheumatoid Arthritis

INTRODUCTION: Biologic disease-modifying anti-rheumatics drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs) are important treatments for rheumatoid arthritis (RA). As more of these drugs become available, there is a greater need to assess their real-world adherence and drug survival. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenberg, Vered, Chodick, Gabriel, Xue, Zhenyi, Faccin, Freddy, Amital, Howard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499743/ https://www.ncbi.nlm.nih.gov/pubmed/37566157 http://dx.doi.org/10.1007/s12325-023-02607-w

Ejemplares similares

Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study
por: Chodick, Gabriel, et al.
Publicado: (2010)

Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients
por: Brehm, Thomas Theo, et al.
Publicado: (2019)

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
por: Busch, Howard, et al.
Publicado: (2022)

SAT-281 Relationship between Socioeconomic Status, Adherence and Outcomes to Growth Hormone Treatment in Children: Real-World Treatment Patterns in Israel
por: Ben-Ari, Tal, et al.
Publicado: (2019)

Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
por: Bertoldi, Ilaria, et al.
Publicado: (2021)

Real‐World Adherence to Oral Methotrexate Measured Electronically in Patients With Established Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2019)

Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient
por: Shobayo, Anuoluwapo, et al.
Publicado: (2019)

Tofacitinib Therapy for Rheumatoid Arthritis: A Direct Comparison Study between Biologic-naïve and Experienced Patients
por: Mori, Shunsuke, et al.
Publicado: (2017)

Real world, big data cost of pharmaceutical treatment for rheumatoid arthritis in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2019)

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
por: Hernández-Cruz, Blanca, et al.
Publicado: (2023)

Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies
por: Numan, Syed, et al.
Publicado: (2018)

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B
por: Kim, Young Min, et al.
Publicado: (2018)

Real-world experience of rituximab biosimilar GP2013 in rheumatoid arthritis patients naïve to or switched from reference rituximab
por: Łosińska, Katarzyna, et al.
Publicado: (2023)

Adherence to Treatment in Patients with Rheumatoid Arthritis from Spain
por: Pombo-Suarez, Manuel, et al.
Publicado: (2021)

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study
por: Grellmann, Claudia, et al.
Publicado: (2020)

Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
por: Melzer-Cohen, Cheli, et al.
Publicado: (2019)

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir
por: D’Ambrosio, Roberta, et al.
Publicado: (2012)

Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004–2015)
por: Ben-Ari, Tal, et al.
Publicado: (2021)

Optimizing management of treatment-naïve and treatment-experienced HIV+ patients: the role of maraviroc
por: Poveda, Eva, et al.
Publicado: (2010)

Treatment patterns, persistence with therapy, and outcomes of ustekinumab in Crohn's disease: Real‐world data analysis
por: Banon, Tamar, et al.
Publicado: (2022)

Real-world retention rates of biologics in patients with rheumatoid arthritis
por: Takami, Kenji, et al.
Publicado: (2023)

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs
por: Boyadzhieva, Vladimira, et al.
Publicado: (2018)

Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept
por: Bonafede, Machaon, et al.
Publicado: (2020)

Real‐World Treatment Effectiveness of Disease‐Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis
por: Jin, Yinzhu, et al.
Publicado: (2023)

Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
por: Gendelman, Omer, et al.
Publicado: (2020)

Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis
por: Gullick, Nicola J., et al.
Publicado: (2019)

Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada
por: Despiégel, Nicolas, et al.
Publicado: (2015)

Real-world effectiveness and safety of tofacitinib and abatacept in patients with rheumatoid arthritis
por: Hirose, Wataru, et al.
Publicado: (2022)

Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
por: Xia, Yunfei, et al.
Publicado: (2016)

Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study
por: Rosenberg, Vered, et al.
Publicado: (2021)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Unmet Needs in Real-World Advanced Therapy-Naïve and -Experienced Patients with Moderately to Severely Active Ulcerative Colitis in the United States
por: Afzali, Anita, et al.
Publicado: (2023)

Inclusion of Synovial Tissue–Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment‐Naive Rheumatoid Arthritis Patients
por: Alivernini, Stefano, et al.
Publicado: (2021)

Real-World Use of Alirocumab: Experience from a Large Healthcare Provider
por: Elis, Avishay, et al.
Publicado: (2023)

Adherence to Methotrexate therapy in Rheumatoid Arthritis
por: Arshad, Nasim, et al.
Publicado: (2016)

Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic‐Naive Rheumatoid Arthritis Patients
por: Kottak, Nicholas, et al.
Publicado: (2018)

Real World Analysis of Small Cell Lung Cancer Patients: Prognostic Factors and Treatment Outcomes
por: Moser, Sarah Sharman, et al.
Publicado: (2021)

Newly diagnosed, treatment-naive patients with rheumatoid arthritis have early abnormalities of vascular and myocardial function
por: Erhayiem, Bara, et al.
Publicado: (2015)

Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients
por: Xie, Yan-Di, et al.
Publicado: (2017)

Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries
por: Taylor, Peter C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ui3vdef6pf3b5l5e4p1m35nimn